Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis

Pediatric Infectious Disease Journal

Volumn 16, Issue 1, 1997, Pages 106-111

  Schaad, Urs B ^a,c   Wedgwood, Joanna ^a   Ruedeberg, Anna ^a   Kraemer, Richard ^a   Hampel, Barbara ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b BAYER AG   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

antipseudomonal; Ciprofloxacin; cystic fibrosis; inhaled amikacin; skeletal toxicity

Indexed keywords

AMIKACIN; CEFTAZIDIME; CIPROFLOXACIN; SALBUTAMOL;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS; SPUTUM CULTURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMIKACIN; ANTI-INFECTIVE AGENTS; CEFTAZIDIME; CHILD; CIPROFLOXACIN; CYSTIC FIBROSIS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

EID: 0031041350     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199701000-00032     Document Type: Conference Paper

References (19)

1. Marks MI. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr 1981;98: 173-9.
2. Hoiby N. Microbiology of lung infections in CF patients. Acta Paediatr Scand 1982;71(Suppl 301):33-54.
3. Kulczycki LL, Murphy TM, Belanti JA. Pseudomonas colonization in cystic fibrosis: a study of 160 patients. JAMA 1978;240:30-4.
4. Boxerbaum B. The art and science of the use of antibiotics in CF. Pediatr Infect Dis 1982;1:381-3.
5. Hoiby N, Friis B, Jense K, et al. Antimicrobial chemotherapy in CF patients. Acta Paediatr Scand 1982;71(Suppl 310):75-100.
6. Smith AL. Antibiotic therapy in cystic fibrosis: evaluation of clinical trials. J Pediatr 1986;108:866-70.
7. Schaad UB, Desgrandchamps D, Kraemer R. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis, a prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin. Acta Paediatr Scand 1986; 75:128-38.
8. Schaad UB, Wedgwood-Krucko J, Guenin U, Buehlmann R, Kraemer R. Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus oral ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin. Eur J Clin Microbiol Infect Dis 1989;8:858-65.
9. Schaad UB, Wedgwood-Krucko J, Suter S, Kraemer R. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. J Pediatr 1987;111:599-605.
10. Bender SW, Dalhoff A, Shah PM, Strehl R, Posselt HG. Ciprofloxacin pharmacokinetics in patients with cystic fibrosis. Antimicrob Agents Chemother 1986;4:614-6.
11. Schaad UB, Salam MA, Aujard Y, et al. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J 1995;14:1-9.
12. Scully BE, Parry MF, Neu HC, Mandell W. Oral ciprofloxacin therapy on infections due to Pseudomonas aeruginosa. Lancet 1986;i:819-22.
13. Gough AW, Kasali OB, Sigler RE, Baragi V. Quinolone arthropathy acute toxicity to immature articular cartilage. Toxicol Pathol 1992;20:436-49.
14. Schaad UB, Wedgwood-Krucko J. Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 1987;15:165-8.
15. Kraemer R, Ruedeberg A, Klay M, Rossi E. Relationship between clinical conditions, radiographic findings and pulmonary functions in patients with cystic fibrosis. Helv Pediatr Acta 1979;34:417-28.
16. Wolfson JS. Quinolone antimicrobial agents: adverse effects and bacterial resistance. Eur J Clin Microbiol Infect Dis 1989;8:1080-92.
17. Schaad UB, Sander E, Wedgwood J, Schaffner T. Morphologic studies of skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr Infect Dis J 1992;11:1047-9.
18. Kubin R. Safety and efficacy of ciprofloxacin in paediatric patients review. Infection 1993;21:413-21.
19. Phillips BM, David TJ. Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med 1986;79(Suppl 12):44-50.